nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomefloxacin—TOP2A—malignant glioma	0.74	1	CbGaD
Lomefloxacin—CYP1A2—Carmustine—malignant glioma	0.133	1	CbGbCtD
Lomefloxacin—Dysphasia—Temozolomide—malignant glioma	0.0053	0.0504	CcSEcCtD
Lomefloxacin—Paranoid reaction—Carmustine—malignant glioma	0.00282	0.0268	CcSEcCtD
Lomefloxacin—Tongue discolouration—Temozolomide—malignant glioma	0.0024	0.0228	CcSEcCtD
Lomefloxacin—Skin hyperpigmentation—Carmustine—malignant glioma	0.00201	0.0191	CcSEcCtD
Lomefloxacin—Cerebration impaired—Temozolomide—malignant glioma	0.00197	0.0187	CcSEcCtD
Lomefloxacin—Aphasia—Carmustine—malignant glioma	0.00185	0.0176	CcSEcCtD
Lomefloxacin—Aphasia—Temozolomide—malignant glioma	0.00179	0.017	CcSEcCtD
Lomefloxacin—Paranoia—Carmustine—malignant glioma	0.00176	0.0167	CcSEcCtD
Lomefloxacin—Trovafloxacin—TOP2A—malignant glioma	0.00174	0.219	CrCbGaD
Lomefloxacin—Influenza-like symptoms—Temozolomide—malignant glioma	0.00162	0.0154	CcSEcCtD
Lomefloxacin—Disturbance in attention—Temozolomide—malignant glioma	0.00134	0.0127	CcSEcCtD
Lomefloxacin—Moxifloxacin—TOP2A—malignant glioma	0.00132	0.166	CrCbGaD
Lomefloxacin—Thinking abnormal—Carmustine—malignant glioma	0.00131	0.0124	CcSEcCtD
Lomefloxacin—Viral infection—Temozolomide—malignant glioma	0.00128	0.0122	CcSEcCtD
Lomefloxacin—Leukocytosis—Carmustine—malignant glioma	0.00127	0.0121	CcSEcCtD
Lomefloxacin—Pulmonary embolism—Carmustine—malignant glioma	0.0012	0.0114	CcSEcCtD
Lomefloxacin—Pulmonary embolism—Temozolomide—malignant glioma	0.00116	0.011	CcSEcCtD
Lomefloxacin—Vaginal inflammation—Temozolomide—malignant glioma	0.00116	0.011	CcSEcCtD
Lomefloxacin—Candida infection—Carmustine—malignant glioma	0.00114	0.0109	CcSEcCtD
Lomefloxacin—Skin exfoliation—Carmustine—malignant glioma	0.00114	0.0109	CcSEcCtD
Lomefloxacin—Influenza like illness—Temozolomide—malignant glioma	0.00112	0.0107	CcSEcCtD
Lomefloxacin—Candida infection—Temozolomide—malignant glioma	0.00111	0.0105	CcSEcCtD
Lomefloxacin—Skin exfoliation—Temozolomide—malignant glioma	0.00111	0.0105	CcSEcCtD
Lomefloxacin—Coma—Carmustine—malignant glioma	0.00109	0.0104	CcSEcCtD
Lomefloxacin—Vaginal infection—Temozolomide—malignant glioma	0.00109	0.0104	CcSEcCtD
Lomefloxacin—Abnormal vision—Carmustine—malignant glioma	0.00104	0.00993	CcSEcCtD
Lomefloxacin—Mental disability—Carmustine—malignant glioma	0.00104	0.00988	CcSEcCtD
Lomefloxacin—Abnormal vision—Temozolomide—malignant glioma	0.00101	0.0096	CcSEcCtD
Lomefloxacin—Phlebitis—Carmustine—malignant glioma	0.00101	0.0096	CcSEcCtD
Lomefloxacin—Mental disability—Temozolomide—malignant glioma	0.001	0.00955	CcSEcCtD
Lomefloxacin—Ear pain—Temozolomide—malignant glioma	0.000985	0.00937	CcSEcCtD
Lomefloxacin—Eye pain—Carmustine—malignant glioma	0.000963	0.00916	CcSEcCtD
Lomefloxacin—Pefloxacin—TOP2A—malignant glioma	0.00096	0.121	CrCbGaD
Lomefloxacin—Vascular purpura—Temozolomide—malignant glioma	0.000939	0.00893	CcSEcCtD
Lomefloxacin—Eye pain—Temozolomide—malignant glioma	0.000931	0.00885	CcSEcCtD
Lomefloxacin—Hot flush—Temozolomide—malignant glioma	0.000898	0.00854	CcSEcCtD
Lomefloxacin—Enoxacin—TOP2A—malignant glioma	0.000898	0.113	CrCbGaD
Lomefloxacin—Dermatitis exfoliative—Temozolomide—malignant glioma	0.000891	0.00847	CcSEcCtD
Lomefloxacin—Menopausal symptoms—Temozolomide—malignant glioma	0.000891	0.00847	CcSEcCtD
Lomefloxacin—Thirst—Temozolomide—malignant glioma	0.000883	0.0084	CcSEcCtD
Lomefloxacin—Purpura—Temozolomide—malignant glioma	0.000872	0.00829	CcSEcCtD
Lomefloxacin—Diplopia—Carmustine—malignant glioma	0.00087	0.00827	CcSEcCtD
Lomefloxacin—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00087	0.00827	CcSEcCtD
Lomefloxacin—Diplopia—Temozolomide—malignant glioma	0.00084	0.00799	CcSEcCtD
Lomefloxacin—Face oedema—Carmustine—malignant glioma	0.00084	0.00798	CcSEcCtD
Lomefloxacin—Sparfloxacin—TOP2A—malignant glioma	0.000827	0.104	CrCbGaD
Lomefloxacin—Ataxia—Carmustine—malignant glioma	0.000818	0.00777	CcSEcCtD
Lomefloxacin—Face oedema—Temozolomide—malignant glioma	0.000811	0.00771	CcSEcCtD
Lomefloxacin—Ataxia—Temozolomide—malignant glioma	0.00079	0.00751	CcSEcCtD
Lomefloxacin—Toxic epidermal necrolysis—Temozolomide—malignant glioma	0.000757	0.0072	CcSEcCtD
Lomefloxacin—Dysphagia—Carmustine—malignant glioma	0.000752	0.00715	CcSEcCtD
Lomefloxacin—Dysphagia—Temozolomide—malignant glioma	0.000726	0.00691	CcSEcCtD
Lomefloxacin—Sweating increased—Temozolomide—malignant glioma	0.000708	0.00673	CcSEcCtD
Lomefloxacin—Dysuria—Temozolomide—malignant glioma	0.000679	0.00646	CcSEcCtD
Lomefloxacin—Hyperglycaemia—Carmustine—malignant glioma	0.000678	0.00645	CcSEcCtD
Lomefloxacin—Photosensitivity reaction—Temozolomide—malignant glioma	0.000663	0.0063	CcSEcCtD
Lomefloxacin—Renal failure—Carmustine—malignant glioma	0.000659	0.00626	CcSEcCtD
Lomefloxacin—Neuropathy peripheral—Carmustine—malignant glioma	0.000657	0.00625	CcSEcCtD
Lomefloxacin—Hyperglycaemia—Temozolomide—malignant glioma	0.000655	0.00623	CcSEcCtD
Lomefloxacin—Stomatitis—Carmustine—malignant glioma	0.000653	0.00621	CcSEcCtD
Lomefloxacin—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.000642	0.0061	CcSEcCtD
Lomefloxacin—Neuropathy peripheral—Temozolomide—malignant glioma	0.000635	0.00604	CcSEcCtD
Lomefloxacin—Stomatitis—Temozolomide—malignant glioma	0.000631	0.006	CcSEcCtD
Lomefloxacin—Hallucination—Carmustine—malignant glioma	0.000599	0.00569	CcSEcCtD
Lomefloxacin—Ofloxacin—TOP2A—malignant glioma	0.000582	0.0733	CrCbGaD
Lomefloxacin—Levofloxacin—TOP2A—malignant glioma	0.000582	0.0733	CrCbGaD
Lomefloxacin—Hepatitis—Temozolomide—malignant glioma	0.000581	0.00553	CcSEcCtD
Lomefloxacin—Visual impairment—Carmustine—malignant glioma	0.00058	0.00551	CcSEcCtD
Lomefloxacin—Hallucination—Temozolomide—malignant glioma	0.000578	0.0055	CcSEcCtD
Lomefloxacin—Pharyngitis—Temozolomide—malignant glioma	0.000577	0.00549	CcSEcCtD
Lomefloxacin—Ciprofloxacin—TOP2A—malignant glioma	0.000562	0.0708	CrCbGaD
Lomefloxacin—Visual impairment—Temozolomide—malignant glioma	0.00056	0.00533	CcSEcCtD
Lomefloxacin—Flushing—Carmustine—malignant glioma	0.000558	0.00531	CcSEcCtD
Lomefloxacin—Erythema multiforme—Temozolomide—malignant glioma	0.00055	0.00523	CcSEcCtD
Lomefloxacin—ABCC2—Irinotecan Pathway—BCHE—malignant glioma	0.000548	0.0397	CbGpPWpGaD
Lomefloxacin—Tinnitus—Temozolomide—malignant glioma	0.000542	0.00515	CcSEcCtD
Lomefloxacin—Flushing—Temozolomide—malignant glioma	0.00054	0.00513	CcSEcCtD
Lomefloxacin—Arrhythmia—Carmustine—malignant glioma	0.000537	0.00511	CcSEcCtD
Lomefloxacin—Chills—Temozolomide—malignant glioma	0.000522	0.00496	CcSEcCtD
Lomefloxacin—Back pain—Carmustine—malignant glioma	0.000507	0.00482	CcSEcCtD
Lomefloxacin—Dysgeusia—Temozolomide—malignant glioma	0.000496	0.00471	CcSEcCtD
Lomefloxacin—Tremor—Carmustine—malignant glioma	0.000491	0.00467	CcSEcCtD
Lomefloxacin—Back pain—Temozolomide—malignant glioma	0.00049	0.00465	CcSEcCtD
Lomefloxacin—Anaemia—Carmustine—malignant glioma	0.000484	0.0046	CcSEcCtD
Lomefloxacin—Agitation—Carmustine—malignant glioma	0.000481	0.00458	CcSEcCtD
Lomefloxacin—Tremor—Temozolomide—malignant glioma	0.000474	0.00451	CcSEcCtD
Lomefloxacin—Norfloxacin—TOP2A—malignant glioma	0.000472	0.0595	CrCbGaD
Lomefloxacin—Ill-defined disorder—Temozolomide—malignant glioma	0.00047	0.00446	CcSEcCtD
Lomefloxacin—Leukopenia—Carmustine—malignant glioma	0.000469	0.00446	CcSEcCtD
Lomefloxacin—Anaemia—Temozolomide—malignant glioma	0.000468	0.00445	CcSEcCtD
Lomefloxacin—TOP2A—Gastric Cancer Network 1—H3F3A—malignant glioma	0.000466	0.0337	CbGpPWpGaD
Lomefloxacin—Agitation—Temozolomide—malignant glioma	0.000465	0.00442	CcSEcCtD
Lomefloxacin—ABCC2—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.000463	0.0336	CbGpPWpGaD
Lomefloxacin—Angioedema—Temozolomide—malignant glioma	0.000462	0.0044	CcSEcCtD
Lomefloxacin—Malaise—Temozolomide—malignant glioma	0.000456	0.00434	CcSEcCtD
Lomefloxacin—Vertigo—Temozolomide—malignant glioma	0.000455	0.00432	CcSEcCtD
Lomefloxacin—Convulsion—Carmustine—malignant glioma	0.000454	0.00431	CcSEcCtD
Lomefloxacin—Leukopenia—Temozolomide—malignant glioma	0.000453	0.00431	CcSEcCtD
Lomefloxacin—Hypertension—Carmustine—malignant glioma	0.000452	0.0043	CcSEcCtD
Lomefloxacin—Chest pain—Carmustine—malignant glioma	0.000446	0.00424	CcSEcCtD
Lomefloxacin—Myalgia—Carmustine—malignant glioma	0.000446	0.00424	CcSEcCtD
Lomefloxacin—Anxiety—Carmustine—malignant glioma	0.000444	0.00422	CcSEcCtD
Lomefloxacin—Cough—Temozolomide—malignant glioma	0.000442	0.0042	CcSEcCtD
Lomefloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.000441	0.032	CbGpPWpGaD
Lomefloxacin—Convulsion—Temozolomide—malignant glioma	0.000439	0.00417	CcSEcCtD
Lomefloxacin—Hypertension—Temozolomide—malignant glioma	0.000437	0.00415	CcSEcCtD
Lomefloxacin—Confusional state—Carmustine—malignant glioma	0.000431	0.0041	CcSEcCtD
Lomefloxacin—Arthralgia—Temozolomide—malignant glioma	0.000431	0.0041	CcSEcCtD
Lomefloxacin—Myalgia—Temozolomide—malignant glioma	0.000431	0.0041	CcSEcCtD
Lomefloxacin—Anxiety—Temozolomide—malignant glioma	0.000429	0.00408	CcSEcCtD
Lomefloxacin—Oedema—Carmustine—malignant glioma	0.000427	0.00406	CcSEcCtD
Lomefloxacin—Discomfort—Temozolomide—malignant glioma	0.000426	0.00405	CcSEcCtD
Lomefloxacin—Dry mouth—Temozolomide—malignant glioma	0.000421	0.00401	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Carmustine—malignant glioma	0.000419	0.00398	CcSEcCtD
Lomefloxacin—Tachycardia—Carmustine—malignant glioma	0.000417	0.00397	CcSEcCtD
Lomefloxacin—Confusional state—Temozolomide—malignant glioma	0.000416	0.00396	CcSEcCtD
Lomefloxacin—Oedema—Temozolomide—malignant glioma	0.000413	0.00393	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Temozolomide—malignant glioma	0.000413	0.00393	CcSEcCtD
Lomefloxacin—Anorexia—Carmustine—malignant glioma	0.000407	0.00387	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Temozolomide—malignant glioma	0.000404	0.00385	CcSEcCtD
Lomefloxacin—Skin disorder—Temozolomide—malignant glioma	0.000401	0.00381	CcSEcCtD
Lomefloxacin—Hypotension—Carmustine—malignant glioma	0.000399	0.0038	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Temozolomide—malignant glioma	0.000399	0.0038	CcSEcCtD
Lomefloxacin—Anorexia—Temozolomide—malignant glioma	0.000394	0.00374	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000389	0.0037	CcSEcCtD
Lomefloxacin—Insomnia—Carmustine—malignant glioma	0.000387	0.00368	CcSEcCtD
Lomefloxacin—Paraesthesia—Carmustine—malignant glioma	0.000384	0.00365	CcSEcCtD
Lomefloxacin—Dyspnoea—Carmustine—malignant glioma	0.000381	0.00362	CcSEcCtD
Lomefloxacin—Somnolence—Carmustine—malignant glioma	0.00038	0.00361	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000376	0.00358	CcSEcCtD
Lomefloxacin—Insomnia—Temozolomide—malignant glioma	0.000374	0.00355	CcSEcCtD
Lomefloxacin—Decreased appetite—Carmustine—malignant glioma	0.000372	0.00353	CcSEcCtD
Lomefloxacin—Paraesthesia—Temozolomide—malignant glioma	0.000371	0.00353	CcSEcCtD
Lomefloxacin—Dyspnoea—Temozolomide—malignant glioma	0.000368	0.0035	CcSEcCtD
Lomefloxacin—Somnolence—Temozolomide—malignant glioma	0.000367	0.00349	CcSEcCtD
Lomefloxacin—Constipation—Carmustine—malignant glioma	0.000366	0.00348	CcSEcCtD
Lomefloxacin—Dyspepsia—Temozolomide—malignant glioma	0.000364	0.00346	CcSEcCtD
Lomefloxacin—Decreased appetite—Temozolomide—malignant glioma	0.000359	0.00341	CcSEcCtD
Lomefloxacin—Fatigue—Temozolomide—malignant glioma	0.000356	0.00339	CcSEcCtD
Lomefloxacin—Constipation—Temozolomide—malignant glioma	0.000353	0.00336	CcSEcCtD
Lomefloxacin—Feeling abnormal—Carmustine—malignant glioma	0.000352	0.00335	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Carmustine—malignant glioma	0.00035	0.00332	CcSEcCtD
Lomefloxacin—Feeling abnormal—Temozolomide—malignant glioma	0.00034	0.00324	CcSEcCtD
Lomefloxacin—Abdominal pain—Carmustine—malignant glioma	0.000338	0.00321	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Temozolomide—malignant glioma	0.000338	0.00321	CcSEcCtD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—STMN1—malignant glioma	0.000334	0.0242	CbGpPWpGaD
Lomefloxacin—Urticaria—Temozolomide—malignant glioma	0.000328	0.00312	CcSEcCtD
Lomefloxacin—Abdominal pain—Temozolomide—malignant glioma	0.000327	0.0031	CcSEcCtD
Lomefloxacin—Hypersensitivity—Carmustine—malignant glioma	0.000315	0.00299	CcSEcCtD
Lomefloxacin—Asthenia—Carmustine—malignant glioma	0.000307	0.00292	CcSEcCtD
Lomefloxacin—Hypersensitivity—Temozolomide—malignant glioma	0.000304	0.00289	CcSEcCtD
Lomefloxacin—CYP1A2—Oxidation by Cytochrome P450—POR—malignant glioma	0.000298	0.0216	CbGpPWpGaD
Lomefloxacin—ABCC2—Irinotecan Pathway—APC—malignant glioma	0.000298	0.0216	CbGpPWpGaD
Lomefloxacin—Asthenia—Temozolomide—malignant glioma	0.000296	0.00282	CcSEcCtD
Lomefloxacin—Diarrhoea—Carmustine—malignant glioma	0.000292	0.00278	CcSEcCtD
Lomefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—FBXW7—malignant glioma	0.000292	0.0212	CbGpPWpGaD
Lomefloxacin—Pruritus—Temozolomide—malignant glioma	0.000292	0.00278	CcSEcCtD
Lomefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—BDKRB2—malignant glioma	0.000287	0.0208	CbGpPWpGaD
Lomefloxacin—Dizziness—Carmustine—malignant glioma	0.000283	0.00269	CcSEcCtD
Lomefloxacin—Diarrhoea—Temozolomide—malignant glioma	0.000283	0.00269	CcSEcCtD
Lomefloxacin—Dizziness—Temozolomide—malignant glioma	0.000273	0.0026	CcSEcCtD
Lomefloxacin—Vomiting—Carmustine—malignant glioma	0.000272	0.00258	CcSEcCtD
Lomefloxacin—Rash—Carmustine—malignant glioma	0.00027	0.00256	CcSEcCtD
Lomefloxacin—Dermatitis—Carmustine—malignant glioma	0.000269	0.00256	CcSEcCtD
Lomefloxacin—Headache—Carmustine—malignant glioma	0.000268	0.00255	CcSEcCtD
Lomefloxacin—Vomiting—Temozolomide—malignant glioma	0.000263	0.0025	CcSEcCtD
Lomefloxacin—Rash—Temozolomide—malignant glioma	0.00026	0.00248	CcSEcCtD
Lomefloxacin—Dermatitis—Temozolomide—malignant glioma	0.00026	0.00247	CcSEcCtD
Lomefloxacin—Headache—Temozolomide—malignant glioma	0.000259	0.00246	CcSEcCtD
Lomefloxacin—Nausea—Carmustine—malignant glioma	0.000254	0.00241	CcSEcCtD
Lomefloxacin—CYP1A2—Xenobiotics—CYP2B6—malignant glioma	0.000253	0.0184	CbGpPWpGaD
Lomefloxacin—Nausea—Temozolomide—malignant glioma	0.000245	0.00233	CcSEcCtD
Lomefloxacin—TOP2A—Gastric Cancer Network 1—NOTCH1—malignant glioma	0.000243	0.0176	CbGpPWpGaD
Lomefloxacin—TOP2A—Gastric Cancer Network 1—APC—malignant glioma	0.000237	0.0172	CbGpPWpGaD
Lomefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—malignant glioma	0.000231	0.0167	CbGpPWpGaD
Lomefloxacin—CYP1A2—Xenobiotics—CYP2C18—malignant glioma	0.00022	0.0159	CbGpPWpGaD
Lomefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—HES1—malignant glioma	0.000219	0.0158	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—NTRK3—malignant glioma	0.000213	0.0155	CbGpPWpGaD
Lomefloxacin—ABCC2—NRF2 pathway—FTH1—malignant glioma	0.000208	0.015	CbGpPWpGaD
Lomefloxacin—CYP1A2—Tryptophan metabolism—ASMT—malignant glioma	0.000183	0.0132	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—STMN1—malignant glioma	0.000178	0.0129	CbGpPWpGaD
Lomefloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.000166	0.012	CbGpPWpGaD
Lomefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—NOTCH1—malignant glioma	0.000165	0.012	CbGpPWpGaD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—APOD—malignant glioma	0.000152	0.011	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—malignant glioma	0.00015	0.0109	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—TUBG2—malignant glioma	0.000142	0.0103	CbGpPWpGaD
Lomefloxacin—ABCC2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000141	0.0102	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PLK1—malignant glioma	0.000135	0.00976	CbGpPWpGaD
Lomefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—malignant glioma	0.000131	0.00949	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—WT1—malignant glioma	0.000128	0.00925	CbGpPWpGaD
Lomefloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—malignant glioma	0.000127	0.00921	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—TUBG2—malignant glioma	0.000127	0.0092	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—malignant glioma	0.000127	0.00917	CbGpPWpGaD
Lomefloxacin—TOP2A—Gastric Cancer Network 2—MYC—malignant glioma	0.000124	0.00897	CbGpPWpGaD
Lomefloxacin—TOP2A—Gastric Cancer Network 2—EGFR—malignant glioma	0.000121	0.00878	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PML—malignant glioma	0.000114	0.00825	CbGpPWpGaD
Lomefloxacin—CYP1A2—Tryptophan metabolism—CYP2C18—malignant glioma	0.000113	0.00817	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—NF1—malignant glioma	0.000113	0.00817	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—PML—malignant glioma	0.000109	0.00792	CbGpPWpGaD
Lomefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.000105	0.00762	CbGpPWpGaD
Lomefloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000104	0.00752	CbGpPWpGaD
Lomefloxacin—TOP2A—Gastric Cancer Network 2—TP53—malignant glioma	0.000102	0.00737	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—COX8A—malignant glioma	9.95e-05	0.00721	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2B—malignant glioma	9.85e-05	0.00714	CbGpPWpGaD
Lomefloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	9.12e-05	0.00661	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—FTH1—malignant glioma	9.1e-05	0.00659	CbGpPWpGaD
Lomefloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	9e-05	0.00652	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	8.53e-05	0.00618	CbGpPWpGaD
Lomefloxacin—ABCC2—NRF2 pathway—SLC5A5—malignant glioma	8.3e-05	0.00602	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—NTRK1—malignant glioma	8.1e-05	0.00587	CbGpPWpGaD
Lomefloxacin—CYP1A2—Arachidonic acid metabolism—PTGS1—malignant glioma	8e-05	0.00579	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ATP1B2—malignant glioma	7.95e-05	0.00576	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—malignant glioma	7.95e-05	0.00576	CbGpPWpGaD
Lomefloxacin—ABCC2—NRF2 pathway—SLC6A3—malignant glioma	7.9e-05	0.00573	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—NTRK1—malignant glioma	7.77e-05	0.00563	CbGpPWpGaD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—malignant glioma	7.76e-05	0.00563	CbGpPWpGaD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RAF1—malignant glioma	7.74e-05	0.00561	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—APOD—malignant glioma	7.74e-05	0.0056	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—malignant glioma	7.53e-05	0.00545	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN2B—malignant glioma	7.46e-05	0.00541	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	7.39e-05	0.00536	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—COX8A—malignant glioma	7.27e-05	0.00527	CbGpPWpGaD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC5A5—malignant glioma	7.16e-05	0.00519	CbGpPWpGaD
Lomefloxacin—CYP1A2—Estrogen Receptor Pathway—STAT3—malignant glioma	7.02e-05	0.00509	CbGpPWpGaD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—SLC6A3—malignant glioma	6.81e-05	0.00494	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—NCOR1—malignant glioma	6.79e-05	0.00492	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PDGFRA—malignant glioma	6.78e-05	0.00491	CbGpPWpGaD
Lomefloxacin—ABCC2—NRF2 pathway—GSTP1—malignant glioma	6.69e-05	0.00485	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—FTH1—malignant glioma	6.65e-05	0.00482	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—PLK1—malignant glioma	6.52e-05	0.00473	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—HIST1H3B—malignant glioma	6.46e-05	0.00468	CbGpPWpGaD
Lomefloxacin—CYP1A2—Tryptophan metabolism—CAT—malignant glioma	6.15e-05	0.00446	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FGFR1—malignant glioma	6.06e-05	0.00439	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—malignant glioma	5.84e-05	0.00423	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—PLK1—malignant glioma	5.83e-05	0.00423	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ATP1B2—malignant glioma	5.81e-05	0.00421	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—HIST1H3B—malignant glioma	5.78e-05	0.00419	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—APOD—malignant glioma	5.66e-05	0.0041	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—malignant glioma	5.63e-05	0.00408	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	5.6e-05	0.00406	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase II conjugation—GSTT1—malignant glioma	5.43e-05	0.00393	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BAD—malignant glioma	5.43e-05	0.00393	CbGpPWpGaD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—malignant glioma	5.42e-05	0.00393	CbGpPWpGaD
Lomefloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	5.3e-05	0.00384	CbGpPWpGaD
Lomefloxacin—ABCC2—NRF2 pathway—PDGFB—malignant glioma	5.29e-05	0.00383	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—APC—malignant glioma	5.26e-05	0.00381	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGF—malignant glioma	5.2e-05	0.00376	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—H3F3A—malignant glioma	4.99e-05	0.00362	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—PPARG—malignant glioma	4.87e-05	0.00353	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—YWHAE—malignant glioma	4.81e-05	0.00348	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—CYP2B6—malignant glioma	4.53e-05	0.00328	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—CYP2B6—malignant glioma	4.47e-05	0.00324	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—H3F3A—malignant glioma	4.46e-05	0.00323	CbGpPWpGaD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—malignant glioma	4.46e-05	0.00323	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FGF2—malignant glioma	4.42e-05	0.00321	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—YWHAE—malignant glioma	4.3e-05	0.00312	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—malignant glioma	4.2e-05	0.00304	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—malignant glioma	4.14e-05	0.003	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RAF1—malignant glioma	4.12e-05	0.00299	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—malignant glioma	4.08e-05	0.00296	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—malignant glioma	3.99e-05	0.00289	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—TFRC—malignant glioma	3.96e-05	0.00287	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—CYP2C18—malignant glioma	3.93e-05	0.00285	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—CYP2C18—malignant glioma	3.87e-05	0.00281	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—malignant glioma	3.82e-05	0.00277	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase II conjugation—GSTP1—malignant glioma	3.76e-05	0.00273	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—malignant glioma	3.7e-05	0.00268	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC5A5—malignant glioma	3.64e-05	0.00263	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2B—malignant glioma	3.61e-05	0.00262	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—malignant glioma	3.48e-05	0.00252	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC6A3—malignant glioma	3.46e-05	0.00251	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—malignant glioma	3.42e-05	0.00248	CbGpPWpGaD
Lomefloxacin—CYP1A2—Tryptophan metabolism—MDM2—malignant glioma	3.4e-05	0.00246	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—malignant glioma	3.39e-05	0.00245	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—PTEN—malignant glioma	3.34e-05	0.00242	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—malignant glioma	3.28e-05	0.00237	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—BRCA2—malignant glioma	3.26e-05	0.00236	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CDKN2B—malignant glioma	3.23e-05	0.00234	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—GSTT1—malignant glioma	3.18e-05	0.0023	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	3.14e-05	0.00228	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—BIRC5—malignant glioma	3.12e-05	0.00226	CbGpPWpGaD
Lomefloxacin—CYP1A2—Arachidonic acid metabolism—PTGS2—malignant glioma	3.06e-05	0.00222	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—malignant glioma	3.05e-05	0.00221	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—malignant glioma	3.04e-05	0.0022	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—PTGS1—malignant glioma	2.98e-05	0.00216	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—TFRC—malignant glioma	2.9e-05	0.0021	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	2.89e-05	0.0021	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	2.83e-05	0.00205	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—BIRC5—malignant glioma	2.79e-05	0.00202	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—TERT—malignant glioma	2.7e-05	0.00196	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	2.69e-05	0.00195	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	2.67e-05	0.00194	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	2.66e-05	0.00193	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—malignant glioma	2.58e-05	0.00187	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	2.53e-05	0.00183	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	2.45e-05	0.00178	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	2.37e-05	0.00172	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—malignant glioma	2.37e-05	0.00172	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—malignant glioma	2.32e-05	0.00168	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—malignant glioma	2.32e-05	0.00168	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—TP53—malignant glioma	2.28e-05	0.00165	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—RTEL1—malignant glioma	2.23e-05	0.00161	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—malignant glioma	2.21e-05	0.0016	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—malignant glioma	2.21e-05	0.0016	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—GSTP1—malignant glioma	2.2e-05	0.0016	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—malignant glioma	2.19e-05	0.00159	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—GSTP1—malignant glioma	2.17e-05	0.00157	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—malignant glioma	2.07e-05	0.0015	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	2.01e-05	0.00145	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CDKN2A—malignant glioma	1.85e-05	0.00134	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—MDM2—malignant glioma	1.79e-05	0.0013	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	1.59e-05	0.00115	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—RAF1—malignant glioma	1.57e-05	0.00114	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	1.54e-05	0.00112	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—MYC—malignant glioma	1.4e-05	0.00101	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—COX8A—malignant glioma	1.28e-05	0.000926	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—MYC—malignant glioma	1.25e-05	0.000907	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—RAF1—malignant glioma	1.15e-05	0.000831	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	1.14e-05	0.000828	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ASMT—malignant glioma	1.09e-05	0.000788	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	1.06e-05	0.00077	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—TP53—malignant glioma	1.03e-05	0.000745	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—BCAN—malignant glioma	1.02e-05	0.000741	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—IDH2—malignant glioma	8.24e-06	0.000597	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	7.77e-06	0.000563	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CYP2B6—malignant glioma	7.75e-06	0.000561	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—IDH1—malignant glioma	7.08e-06	0.000513	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SPHK1—malignant glioma	6.86e-06	0.000497	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CYP2C18—malignant glioma	6.72e-06	0.000487	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	6.33e-06	0.000459	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	5.77e-06	0.000418	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	5.57e-06	0.000403	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GSTT1—malignant glioma	5.43e-06	0.000394	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PTGS1—malignant glioma	5.09e-06	0.000369	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	5.07e-06	0.000367	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—BCHE—malignant glioma	4.73e-06	0.000343	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SLC5A5—malignant glioma	4.67e-06	0.000339	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	4.42e-06	0.00032	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	4.38e-06	0.000317	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	3.82e-06	0.000277	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GSTP1—malignant glioma	3.77e-06	0.000273	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CAT—malignant glioma	3.66e-06	0.000265	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—NCOR1—malignant glioma	3.46e-06	0.000251	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CAV1—malignant glioma	2.82e-06	0.000204	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	2.69e-06	0.000195	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PIK3CG—malignant glioma	2.57e-06	0.000186	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PPARG—malignant glioma	2.48e-06	0.00018	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PIK3CD—malignant glioma	2.26e-06	0.000164	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PIK3CB—malignant glioma	1.97e-06	0.000143	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PTGS2—malignant glioma	1.95e-06	0.000141	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PTEN—malignant glioma	1.7e-06	0.000123	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PIK3CA—malignant glioma	1.2e-06	8.7e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—AKT1—malignant glioma	9.8e-07	7.1e-05	CbGpPWpGaD
